Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-taking and broader market caution rather than negative news. This suggests investors are repositioning amid volatility, even as companies report strong results or progress. The market may see continued fluctuations as investors balance optimism with risk management.
The recent sharp declines in several high-volume stocks like ITG Inc and Adicet Bio provide context for market activity today. For readers following the health sector, here is Pluang's market snapshot as of Sep 29, 2026 04:11 WIB: out of 100 priced US health stocks, 52 rose and 47 fell. Notable movers include REGN at USD 750.00 with a -4.83% change and a typical hold time of 106 days, FLNA at USD 0.74 down 4.23% with 27% sell and 73% buy order activity, and AMPH at USD 27.20 up 4.09% with 1% sell and 99% buy order activity and a typical hold time of 16 days.
Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...
A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...
Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...
Conagra Brands is set to report Q1 earnings with analysts forecasting a 1.4% revenue decline to about $2.59 billion due to weak consumer spending and inflation. Earnings per share are expected to drop 20.5% to $0.31, reflecting margin pressures and a...
Morgan Stanley raised the price target for Reinsurance Group of America (RGA) to $295, implying a 16.7% upside from its current price of $252.85. The company reported a 42% increase in adjusted operating income to $746 million in H1, driven by its lo...
